Study findings provide a new gene pathway for potential treatment of the virus affecting millions. Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor ...

To cut out this virus, the team used CRISPR-Cas gene ... managing to completely inactivate HIV with a single guide RNA and ...

The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

Once HIV has bound to CD4, it activates other proteins on the surface of the human cell known as CCR5 and CXCR4 in order to complete its fusion with the cell. Once fusion has occurred, the inside of ...

The device demonstrated a detection limit of 30 copies/mL of HIV RNA, a level comparable to traditional laboratory methods, with no cross-reactivity to hepatitis C virus (HCV). Clinical testing ...

To become infectious, HIV has to undergo a maturation process, which involves a rearrangement of the matrix proteins (red). In an immature virus particle, the matrix proteins form a lose lattice ...

It doesn't import its RNA genetic material ... capsid—basically the whole virus minus its outer membrane—through the nuclear pore in one piece. The HIV-1 capsid protein makes up most of ...

Results show similar levels of virus undetectability in patients on ibalizumab-containing regimens as in controls, despite greater baseline ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.

Incident HCV infection more than doubled among HIV-positive MSM with no history of injection drug use between 1995 and 2023.